Does variable RBE affect toxicity risks for mediastinal lymphoma patients? NTCP-based evaluation after proton therapy treatment
- 27 March 2023
- journal article
- research article
- Published by Elsevier in Physica Medica
- Vol. 108, 102569
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Multivariate Normal Tissue Complication Probability Modeling of Heart Valve Dysfunction in Hodgkin Lymphoma SurvivorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approachRadiotherapy and Oncology, 2013
- Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast CancerNew England Journal of Medicine, 2013
- Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysisRadiation Oncology, 2012
- Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiationJournal of Radiation Research, 2012
- TOPAS: An innovative proton Monte Carlo platform for research and clinical applicationsMedical Physics, 2012
- Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphomaAnnals of Oncology, 2012
- The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancerPhysics in Medicine & Biology, 2005
- Quantitative clinical radiobiology of early and late lung reactionsInternational Journal of Radiation Biology, 2000